2.85
price down icon6.86%   -0.21
after-market Handel nachbörslich: 2.81 -0.04 -1.40%
loading
Schlusskurs vom Vortag:
$3.06
Offen:
$3.1
24-Stunden-Volumen:
3.34M
Relative Volume:
1.51
Marktkapitalisierung:
$384.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-5.00
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
-11.49%
1M Leistung:
+4.01%
6M Leistung:
+261.13%
1J Leistung:
+83.87%
1-Tages-Spanne:
Value
$2.71
$3.10
1-Wochen-Bereich:
Value
$2.71
$3.27
52-Wochen-Spanne:
Value
$0.4603
$7.13

Prokidney Corp Stock (PROK) Company Profile

Name
Firmenname
Prokidney Corp
Name
Telefon
336-999-7028
Name
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Name
Mitarbeiter
204
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-09
Name
Neueste SEC-Einreichungen
Name
PROK's Discussions on Twitter

Vergleichen Sie PROK mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PROK
Prokidney Corp
2.85 416.09M 0 -35.47M -124.27M -0.57
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Prokidney Corp Stock (PROK) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-30 Herabstufung BofA Securities Neutral → Underperform
2024-09-30 Eingeleitet JP Morgan Neutral
2024-09-10 Eingeleitet Guggenheim Buy
2024-03-07 Fortgesetzt Morgan Stanley Equal-Weight
2024-01-02 Herabstufung BofA Securities Buy → Neutral
2023-07-25 Eingeleitet BTIG Research Buy
2022-12-21 Eingeleitet Jefferies Buy
2022-11-10 Eingeleitet Morgan Stanley Equal-Weight
2022-10-18 Eingeleitet UBS Buy
2022-10-14 Eingeleitet Citigroup Buy
2022-09-23 Eingeleitet BofA Securities Buy
2022-09-02 Eingeleitet Evercore ISI Outperform
Alle ansehen

Prokidney Corp Aktie (PROK) Neueste Nachrichten

pulisher
09:31 AM

Will ProKidney Corp. stock beat EPS estimatesQuarterly Profit Summary & Reliable Trade Execution Plans - newser.com

09:31 AM
pulisher
08:56 AM

Is now a turning point for ProKidney Corp.Quarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com

08:56 AM
pulisher
06:38 AM

Is ProKidney Corp. stock poised for growthWeekly Trade Summary & Daily Volume Surge Signals - newser.com

06:38 AM
pulisher
04:53 AM

Automated trading signals detected on ProKidney Corp.Weekly Trend Recap & AI Driven Stock Movement Reports - newser.com

04:53 AM
pulisher
04:30 AM

What candlestick patterns are forming on ProKidney Corp.2025 Performance Recap & Entry Point Strategy Guides - newser.com

04:30 AM
pulisher
Nov 02, 2025

Heatmap analysis for ProKidney Corp. and competitorsJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What valuation multiples suggest for ProKidney Corp. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What to expect from ProKidney Corp. in the next 30 daysPortfolio Profit Report & Trade Opportunity Analysis - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Visual analytics tools that track ProKidney Corp. performancePortfolio Update Report & Weekly Setup with High ROI Potential - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will ProKidney Corp. stock recover faster than peersShare Buyback & Verified Momentum Stock Watchlist - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will ProKidney Corp. stock go up soonRisk Management & Long-Term Safe Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

How ProKidney Corp. stock performs in stagflationSwing Trade & Community Trade Idea Sharing - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

What technical charts say about ProKidney Corp. stockJuly 2025 EndofMonth & Growth Oriented Trading Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 29, 2025

ProKidney (NASDAQ:PROK) Shares Down 8.2%Should You Sell? - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference - The Manila Times

Oct 29, 2025
pulisher
Oct 28, 2025

Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025 - Investing News Network

Oct 28, 2025
pulisher
Oct 27, 2025

Guidance Update: Can ProKidney Corp. stock weather global recessionJuly 2025 Institutional & Daily Risk Controlled Trade Plans - fcp.pa.gov.br

Oct 27, 2025

Finanzdaten der Prokidney Corp-Aktie (PROK)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):